clinical trial · NCT04470622
Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)
COVID-19Aprepitant injectable emulsionSaline Placebo
brief summary
The study will evaluate the efficacy and safety of aprepitant injectable emulsion added to standard of care for hospitalized patients with COVID-19.
started
Jul 20, 2020
primary completion
Apr 9, 2021
completion
Jun 3, 2021
last updated
Mar 2, 2026
official title
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of Aprepitant Injectable Emulsion in Early Hospitalized Adult Patients With COVID-19
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol